Senior insider sale
Chief Scientific Officer at CANDEL THERAPEUTICS, INC. — senior position signals high conviction
$229.5K
23.45K shares
What this filing means
BARONE FRANCESCA plans to sell 23.45K shares of CANDEL THERAPEUTICS, INC. valued at approximately $229.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/29/2026ACC: 0001950047-26-006597
Officer· Chief Scientific Officer
Since Feb 2022
23.45K
Shares to sell
$229.5K
Approx. market value
23.45K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
1/7/2025
23.45KTotal acquired23.45K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/7/2025 | Restricted Stock Units N/A | 23.45K | — |
| Total | 23.45K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
23.45K
Market value
$229.5K
6/29/2026
Total
Units
23.45K
Value
$229.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/29/2026 | 23.45K | $229.5K | NASDAQ | Planned |
| Total | 23.45K | $229.5K | ||